Financials
Value Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 30.38 M52.25 M47.05 M43.77 M 173.45 M Research & development 56.37 M87.62 M91.74 M122.36 M 358.1 M Operating income -80.57 M-134.76 M-132.96 M-158.12 M -506.41 M Non-Operating Income, Total -353.76 M-2.23 M25.34 M22.93 M -307.72 M Interest expense, net of interest capitalized 3.46 M3.76 M3.62 M3.66 M 14.5 M Non-Operating Income, excl. Interest Expenses -836 K9.04 M10.86 M9.63 M 28.7 M Unusual income/expense -356.39 M-15.03 M10.86 M9.63 M -350.92 M Pretax income -436.96 M-149.78 M-122.09 M-148.49 M -857.32 M Equity in earnings ———— — Taxes 253 K176 K216 K267 K 912 K Non-controlling/minority interest ———— — After tax other income/expense ——-119 K-201 K — Net income before discontinued operations -437.21 M-149.96 M-122.31 M-148.75 M -858.24 M Discontinued operations ———— — Net income -437.21 M-149.96 M-122.31 M-148.75 M -858.24 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -451.81 M-328.18 M-122.31 M-148.75 M -1.05 B Basic earnings per share (Basic EPS) -9.830.98-0.53-0.64 -10.02 Diluted earnings per share (Diluted EPS) -9.830.98-0.53-0.64 -10.02 Average basic shares outstanding 45.95 M74.97 M229.64 M231.98 M — Diluted shares outstanding 45.95 M74.97 M229.64 M231.98 M — EBITDA -74.78 M-129.04 M-126.81 M— — EBIT -80.57 M-134.76 M-132.96 M-158.12 M -506.4 M Cost of revenue 2.74 M4.23 M4.3 M6.64 M 17.91 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 5.79 M5.71 M6.15 M6.32 M 23.98 M